Tekla Life Sciences Investors ( HQL) - Dividend Growth Rate (DGR)
HQL Dividend Growth Rate for past 3 years (DGR3)
Dividend history for stock HQL (Tekla Life Sciences Investors) including dividend growth rate predictions based on history.
| Year | Dividend | Estimated Yield on Cost |
|---|---|---|
| 2036 | 4.250USD | 25.74% |
| 2035 | 3.934USD | 23.83% |
| 2034 | 3.643USD | 22.06% |
| 2033 | 3.372USD | 20.43% |
| 2032 | 3.122USD | 18.91% |
| 2031 | 2.890USD | 17.51% |
| 2030 | 2.676USD | 16.21% |
| 2029 | 2.477USD | 15.01% |
| 2028 | 2.294USD | 13.89% |
| 2027 | 2.123USD | 12.86% |
| 2026 | 1.966USD | 11.91% |
HQL Dividend Growth Rate for past 5 years (DGR5)
| Year | Dividend | Estimated Yield on Cost |
|---|---|---|
| 2036 | 3.894USD | 23.58% |
| 2035 | 3.633USD | 22.01% |
| 2034 | 3.391USD | 20.54% |
| 2033 | 3.164USD | 19.17% |
| 2032 | 2.953USD | 17.89% |
| 2031 | 2.756USD | 16.69% |
| 2030 | 2.572USD | 15.58% |
| 2029 | 2.400USD | 14.54% |
| 2028 | 2.239USD | 13.56% |
| 2027 | 2.090USD | 12.66% |
| 2026 | 1.950USD | 11.81% |
HQL Dividend Growth Rate for past 10 years (DGR10)
| Year | Dividend | Estimated Yield on Cost |
|---|---|---|
| 2036 | 1.956USD | 11.85% |
| 2035 | 1.943USD | 11.77% |
| 2034 | 1.931USD | 11.69% |
| 2033 | 1.918USD | 11.62% |
| 2032 | 1.906USD | 11.54% |
| 2031 | 1.893USD | 11.47% |
| 2030 | 1.881USD | 11.39% |
| 2029 | 1.868USD | 11.32% |
| 2028 | 1.856USD | 11.24% |
| 2027 | 1.844USD | 11.17% |
| 2026 | 1.832USD | 11.10% |
HQL
Price: $16.51
Dividend Yield: 11.81%
Forward Dividend Yield: 13.57%
Payout Ratio: 146.27%
Dividend Per Share: 2.24 USD
Earnings Per Share: 2.79 USD
P/E Ratio: 5.77
Exchange: NYQ
Sector: Financial Services
Industry: Asset Management
Country: United States
Volume: 93486
Market Capitalization: 525.1 million
Average Dividend Frequency: 4
Years Paying Dividends: 31
DGR3: 8.01%
DGR5: 7.16%
DGR10: 0.66%
DGR20: 22.46%